These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39032066)

  • 1. Role of palmitoylation on the neuronal glycine transporter GlyT2.
    Felipe R; Sarmiento-Jiménez J; Camafeita E; Vázquez J; López-Corcuera B
    J Neurochem; 2024 Sep; 168(9):2056-2072. PubMed ID: 39032066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of the dominant negative effect of a glycine transporter 2 mutation associated with hyperekplexia.
    Arribas-González E; de Juan-Sanz J; Aragón C; López-Corcuera B
    J Biol Chem; 2015 Jan; 290(4):2150-65. PubMed ID: 25480793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuronal glycine transporter GLYT2 associates with membrane rafts: functional modulation by lipid environment.
    Núñez E; Alonso-Torres P; Fornés A; Aragón C; López-Corcuera B
    J Neurochem; 2008 Jun; 105(6):2080-90. PubMed ID: 18266927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic control of glycine transporter 2 (GlyT2) by physical and functional association with plasma membrane Ca2+-ATPase (PMCA) and Na+-Ca2+ exchanger (NCX).
    de Juan-Sanz J; Núñez E; Zafra F; Berrocal M; Corbacho I; Ibáñez I; Arribas-González E; Marcos D; López-Corcuera B; Mata AM; Aragón C
    J Biol Chem; 2014 Dec; 289(49):34308-24. PubMed ID: 25315779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Na+/K+-ATPase is a new interacting partner for the neuronal glycine transporter GlyT2 that downregulates its expression in vitro and in vivo.
    de Juan-Sanz J; Núñez E; Villarejo-López L; Pérez-Hernández D; Rodriguez-Fraticelli AE; López-Corcuera B; Vázquez J; Aragón C
    J Neurosci; 2013 Aug; 33(35):14269-81. PubMed ID: 23986260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperekplexia-associated mutations in the neuronal glycine transporter 2.
    López-Corcuera B; Arribas-González E; Aragón C
    Neurochem Int; 2019 Feb; 123():95-100. PubMed ID: 29859229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocytosis of the neuronal glycine transporter GLYT2: role of membrane rafts and protein kinase C-dependent ubiquitination.
    de Juan-Sanz J; Zafra F; López-Corcuera B; Aragón C
    Traffic; 2011 Dec; 12(12):1850-67. PubMed ID: 21910806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2.
    Giménez C; Pérez-Siles G; Martínez-Villarreal J; Arribas-González E; Jiménez E; Núñez E; de Juan-Sanz J; Fernández-Sánchez E; García-Tardón N; Ibáñez I; Romanelli V; Nevado J; James VM; Topf M; Chung SK; Thomas RH; Desviat LR; Aragón C; Zafra F; Rees MI; Lapunzina P; Harvey RJ; López-Corcuera B
    J Biol Chem; 2012 Aug; 287(34):28986-9002. PubMed ID: 22753417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E3 ubiquitin ligases LNX1 and LNX2 are major regulators of the presynaptic glycine transporter GlyT2.
    de la Rocha-Muñoz A; Núñez E; Arribas-González E; López-Corcuera B; Aragón C; de Juan-Sanz J
    Sci Rep; 2019 Oct; 9(1):14944. PubMed ID: 31628376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescue of two trafficking-defective variants of the neuronal glycine transporter GlyT2 associated to hyperekplexia.
    de la Rocha-Muñoz A; Melgarejo E; Aragón C; López-Corcuera B
    Neuropharmacology; 2021 May; 189():108543. PubMed ID: 33794243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular localization of the neuronal glycine transporter GLYT2 in brainstem.
    Núñez E; Pérez-Siles G; Rodenstein L; Alonso-Torres P; Zafra F; Jiménez E; Aragón C; López-Corcuera B
    Traffic; 2009 Jul; 10(7):829-43. PubMed ID: 19374720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease.
    Carta E; Chung SK; James VM; Robinson A; Gill JL; Remy N; Vanbellinghen JF; Drew CJ; Cagdas S; Cameron D; Cowan FM; Del Toro M; Graham GE; Manzur AY; Masri A; Rivera S; Scalais E; Shiang R; Sinclair K; Stuart CA; Tijssen MA; Wise G; Zuberi SM; Harvey K; Pearce BR; Topf M; Thomas RH; Supplisson S; Rees MI; Harvey RJ
    J Biol Chem; 2012 Aug; 287(34):28975-85. PubMed ID: 22700964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The glycine transporter GlyT2 controls the dynamics of synaptic vesicle refilling in inhibitory spinal cord neurons.
    Rousseau F; Aubrey KR; Supplisson S
    J Neurosci; 2008 Sep; 28(39):9755-68. PubMed ID: 18815261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2X receptors up-regulate the cell-surface expression of the neuronal glycine transporter GlyT2.
    Villarejo-López L; Jiménez E; Bartolomé-Martín D; Zafra F; Lapunzina P; Aragón C; López-Corcuera B
    Neuropharmacology; 2017 Oct; 125():99-116. PubMed ID: 28734869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease.
    Rees MI; Harvey K; Pearce BR; Chung SK; Duguid IC; Thomas P; Beatty S; Graham GE; Armstrong L; Shiang R; Abbott KJ; Zuberi SM; Stephenson JB; Owen MJ; Tijssen MA; van den Maagdenberg AM; Smart TG; Supplisson S; Harvey RJ
    Nat Genet; 2006 Jul; 38(7):801-6. PubMed ID: 16751771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycine transporters GlyT1 and GlyT2 are differentially modulated by glycogen synthase kinase 3β.
    Jiménez E; Núñez E; Ibáñez I; Zafra F; Aragón C; Giménez C
    Neuropharmacology; 2015 Feb; 89():245-54. PubMed ID: 25301276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia.
    Eulenburg V; Becker K; Gomeza J; Schmitt B; Becker CM; Betz H
    Biochem Biophys Res Commun; 2006 Sep; 348(2):400-5. PubMed ID: 16884688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presynaptic glycine transporter GlyT2 is regulated by the Hedgehog pathway in vitro and in vivo.
    de la Rocha-Muñoz A; Núñez E; Vishwanath AA; Gómez-López S; Dhanasobhon D; Rebola N; López-Corcuera B; de Juan-Sanz J; Aragón C
    Commun Biol; 2021 Oct; 4(1):1197. PubMed ID: 34663888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of glycine transporter GlyT2 mutations in startle disease.
    James VM; Gill JL; Topf M; Harvey RJ
    Biol Chem; 2012 Apr; 393(4):283-9. PubMed ID: 22114948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive endocytosis and turnover of the neuronal glycine transporter GlyT2 is dependent on ubiquitination of a C-terminal lysine cluster.
    de Juan-Sanz J; Núñez E; López-Corcuera B; Aragón C
    PLoS One; 2013; 8(3):e58863. PubMed ID: 23484054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.